Dermatol. praxi. 2013;7(2):73-76

Mutilating form of psoriatic spondylitis

MUDr.Marcela Brenerová1, MUDr.Alena Machovcová, MBA1, MUDr.Yvetta Vantuchová, Ph.D.2
1 Dermatovenerologické oddělení FN Motol, Praha
2 Kožní oddělení FN Ostrava

Case report describes a 57-year-old man with a long-term chronic psoriasis treated only with methotrexate in combination with non-steroidal

anti-inflammatory drugs. In relatively short time psoriasis has transformed into psoriatic spondylitis and psoriatic arthropathy of

the fifth degree. This case shows how important it is to start proper treatment earlier before appears irreversible change in joints. Early

recognition of psoriatic arthritis by dermatologist and close cooperation with the rheumatologist may significantly affect the prognosis

and quality of life.

Keywords: psoriasis, psoriatic arthritis, psoriatic spondylitis, treatment

Published: July 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brenerová M, Machovcová A, Vantuchová Y. Mutilating form of psoriatic spondylitis. Dermatol. praxi. 2013;7(2):73-76.
Download citation

References

  1. Braun-Falco O, Plewig G, Wolf HH. Dermatológia a venerológia, Prvé slovenské a české vydanie, Vydavatelství Osveta 2001: 502-503.
  2. Cantini F, Nicolli L, Nannini C. Psoriatic arthritis: a systematic review, Int J Rheum Dis 2010; 13: 300-317. Go to original source... Go to PubMed...
  3. Fry L. An atlas of psoriasi, Informa Healthacare 2004: 37-40.
  4. Gladman DD. Psoriatic arthritis, Dermatol Ther 2009; 22(1): 40-55. Go to original source... Go to PubMed...
  5. Christophers E, Barker J, Griffiths C, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patiens seen in European dermatology clinics, J Eur Acad Dermatol Venerol 2009; 24(5): 548-554. Go to original source... Go to PubMed...
  6. Laws P, Barton A, Warren RB. Psoriatic arthritis - what the dermatologist needs to know, J Eur Acad Dermatol Venerol 2010; 24(11): 1270-1277. Go to original source... Go to PubMed...
  7. Pavelka K. Postavení biologické léčby anti-TNF? preparáty v léčbě revmatoidní artritidy, Biologická léčba 2008; 1: 7-12.
  8. Vencovský J. Bezpečnost biologické léčby - doporučení České revmatologické společnosti, Čes. Revmatol. 2009; 17(3): 146-160.
  9. Štolfa J, Vencovský J, Pavelka K. Doporučené postupy České revmatologické společnosti pro léčbu psoriatické artritidy, Čes.Revmatologie 2012; 20(1): 13-18.
  10. Štork J, Arenberger P, Pizinger K. Dermatovenerologie, 1. vydání, Praha: Galén, 2008: 185-191.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.